Last $15.48 USD
Change Today +0.49 / 3.27%
Volume 533.1K
STML On Other Exchanges
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Eric K. Rowinsky M.D.

Chief Medical Officer, Head of Research & Development and Executive Vice President, Stemline Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 92 board members in 9 different organizations across 17 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Eric K. Rowinsky, M.D. has been the Chief Medical Officer, Head of Research & Development and Executive Vice President at Stemline Therapeutics, Inc., since November 2011. Dr. Rowinsky has been a Consultant at Coronado Biosciences, Inc., since October 2010. He serves as Consultant/Scientific Advisor to multiple biotech and pharmaceutical companies in cancer drug development. He has been an Independent Consultant since January 2010. He has been Strategic Advisor for ...

Read Full Background

Corporate Headquarters*

750 Lexington Avenue
New York, New York 10022

United States

Phone: 646-502-2311
Fax: 646-389-0968

Board Members Memberships*

Former Director and Member of Oncology Scientific Advisory Board
Former Director and Member of Special Committee
Independent Director, Member of Compensation & Management Development Committee, Member of Science & Technology Committee and Member of Corporate Governance Committee
Chairman of the Scientific Advisory Board and Director
Vice Chairman, Consultant and Member of Strategic Transaction Committee
Director and Member of Nominating & Corporate Governance Committee


New York University
School of Medicine, Vanderbilt University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$257,500
Total Calculated Compensation$310,600
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STML:US $15.48 USD +0.49


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STEMLINE THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at